MET and cancer: Tumor suppressor miRNA, miR34a, is believed to be frequently depleted in cancer tissues and it is associated with the genetic expression of multiple signaling pathways, including NOTCH-1, CD44, Bcl-2, Myc, Met, CDK-4/6, and various other biological molecules [33].